depalmitoaser

Depalmitoaser is a term that appears in limited or informal discussions as a name for an enzyme or catalytic activity that removes palmitoyl groups from lipid-modified proteins. It is not listed as a canonical enzyme in major biochemical databases, and its exact definition may vary by source. The word seems to be constructed from depalmitoylation and the common enzyme-suffix -ase.

In a hypothetical sense, a depalmitoaser would catalyze hydrolysis of thioester bonds linking palmitoyl groups to cysteine residues (S-palmitoylation) or other attachment sites, thereby converting palmitoylated substrates to their depalmitoylated forms. Real-world depalmitoylation activity is carried out by enzymes such as acyl-protein thioesterases APT1 (LYPLA1) and APT2 (LYPLA2), PPT1, and members of the ABHD17 family, among others. These enzymes regulate localization, stability, and signaling of palmitoylated proteins.

Biological significance: dynamic palmitoylation-depalmitoylation cycles influence membrane association and trafficking, synaptic function, and signal transduction. Misregulation has been linked to neurological disorders, cancer, and infectious diseases in some studies.

Detection and study: researchers study depalmitoylation using chemical labeling methods and acyl-biotin exchange, mass spectrometry, and genetic manipulation to observe effects on substrates.

See also: palmitoylation, depalmitoylation, acyl-protein thioesterases, PPT1, ABHD17.